- BGN1.02bn
- BGN1.31bn
- BGN1.89bn
- 33
- 90
- 49
- 60
Annual balance sheet for Sopharma AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 27.4 | 25.1 | 37.7 | 19.9 | 129 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 279 | 282 | 253 | 247 | 290 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 549 | 612 | 571 | 572 | 787 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 379 | 396 | 362 | 376 | 358 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,175 | 1,242 | 1,205 | 1,254 | 1,514 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 484 | 544 | 424 | 407 | 609 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 619 | 689 | 558 | 549 | 776 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 556 | 553 | 647 | 705 | 738 |
| Total Liabilities & Shareholders' Equity | 1,175 | 1,242 | 1,205 | 1,254 | 1,514 |
| Total Common Shares Outstanding |